Preliminary study of real-time three-dimensional dobutamine stress echocardiography for coronary artery disease assessment

National Medical Journal of China

Volumn 92, Issue 39, 2012, Pages 2747-2751

  Xu, Yong ^a   Liu, Jun Song ^a   Zhi, Guang ^a   Wang, Jing ^a   Ou, Shu Lin ^a   Yang, Bo ^a   Zhou, Xiao ^a   Chen, Guang Hui ^a  

^a Hainan Branch of PLA General Hospital   (China)

Author keywords

Coronary artery disease; Dobutamine; Echocardiography, three dimensional

Indexed keywords

DOBUTAMINE;

ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL ARTICLE; CORONARY ARTERY DISEASE; HEART EJECTION FRACTION; HEART VENTRICLE WALL MOTION; HUMAN; PARAMETERS; PATIENT SAFETY; PREDICTIVE VALUE; REAL TIME THREE DIMENSIONAL DOBUTAMINE STRESS ECHOCARDIOGRAPHY; SENSITIVITY AND SPECIFICITY; STRESS ECHOCARDIOGRAPHY; THREE DIMENSIONAL IMAGING;

ADULT; CORONARY ANGIOGRAPHY; CORONARY DISEASE; DOBUTAMINE; ECHOCARDIOGRAPHY, STRESS; ECHOCARDIOGRAPHY, THREE-DIMENSIONAL; EXERCISE TEST; FEMALE; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY;

EID: 84872150962     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0376-2491.2012.39.004     Document Type: Article

References (8)

1. Nesto R W, Kowalchuk G J. The ischemic cascade: temporal sequence of hemodynamic, electrocardiographic and symptomatic expressions of ischemia. Am J Cardiol, 1987, 59: 23C-30C.
2. Biagini E, Schinkel A F, Bax J J, et al. Long term outcome in patients with silent versus symptomatic ischaemia during dobutamine stress echocardiography. Heart, 2005, 91: 737-742.
3. Cershlick A H, de Belder M, Chambers J, et al. Role of non-invasive imaging in the management of coronary artery disease: an assessment of likely change over the next 10 years. A report from the British Cardiovascular Society Working Group. Heart, 2007, 93: 423-431.
4. Matsumura Y, Hozumi T, Arai K, et al. Non-invasive assessment of myocardial ischaemia using new real-time three-dimensional dobutamine stress echocardiography: comparison with conventional two-dimensional methods. Eur Heart J, 2005, 26: 1625-1632.
5. Aggeli C, Giannopoulos G, Misovoulos P, et al. Real-time three-dimensional dobutamine stress echocardiography for coronary artery disease diagnosis: validation with coronary angiography. Heart, 2007, 93: 672-675.
6. Rizzello V, Poldermans D, Schinkel A F, et al. Long term prognostic value of myocardial viability and ischaemia during dobutamine stress echocardiography in patients with ischaemic cardiomyopathy undergoing coronary revascularisation. Heart, 2006, 92: 239-244.
7. Camici P G, Prasad S K, Rimoldi O E. Stunning, hibernation, and assessment of myocardial viability. Circulation, 2008, 117: 103-114.
8. Geleijnse M L, Krenning B J, Nemes A, et al. Incidence, pathophysiology, and treatment of complications during dobutamine-atropine stress echocardiography. Circulation, 2010, 121: 1756-1767.